Guard Therapeutics International AB (publ) GUARD.ST
GUARD.ST
Guard Therapeutics International AB (publ) XBRANE.ST
Xbrane Biopharma AB (publ) IVACC.ST
Intervacc AB (publ) MAGLE.ST
Magle Chemoswed Holding AB (publ) ACE.ST
Ascelia Pharma AB (publ) IMMU.ST
Mendus AB (publ) CLBIO.ST
Corline Biomedical AB MOB.ST
Moberg Pharma AB (publ) ELIC.ST
Elicera Therapeutics AB (publ) XINT.ST
Xintela AB (publ)
Guard Therapeutics International AB (publ) XBRANE.ST
Xbrane Biopharma AB (publ) IVACC.ST
Intervacc AB (publ) MAGLE.ST
Magle Chemoswed Holding AB (publ) ACE.ST
Ascelia Pharma AB (publ) IMMU.ST
Mendus AB (publ) CLBIO.ST
Corline Biomedical AB MOB.ST
Moberg Pharma AB (publ) ELIC.ST
Elicera Therapeutics AB (publ) XINT.ST
Xintela AB (publ)
Performance
| Periode | GUARD.ST | XBRANE.ST | IVACC.ST | MAGLE.ST | ACE.ST | IMMU.ST | CLBIO.ST | MOB.ST | ELIC.ST | XINT.ST |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 79.84 % | -52.70 % | 8.66 % | -33.33 % | 3.47 % | 24.23 % | 105.07 % | 2.28 % | 62.14 % | 23.80 % |
| YTD | 19.77 % | -49.39 % | 20.23 % | -49.47 % | 2.12 % | -27.98 % | 102.93 % | -20.45 % | 256.90 % | 18.10 % |
| 1Y | 8.01 % | -56.40 % | -61.52 % | -46.46 % | 50.00 % | -40.39 % | 140.69 % | -27.57 % | 263.16 % | -5.73 % |
| 3Y | -31.84 % | -99.87 % | -95.70 % | -27.55 % | -82.62 % | -85.63 % | 127.70 % | -43.94 % | 51.46 % | -2.14 % |
| 5Y | -64.68 % | -99.88 % | -97.12 % | -41.50 % | -92.11 % | -96.61 % | 14.99 % | -87.42 % | 0.16 % | -87.47 % |
| 10Y | -99.17 % | -99.73 % | -81.63 % | -4.43 % | -87.40 % | -98.96 % | 71.98 % | -97.42 % | 0.16 % | -90.14 % |
| Depuis le début | -99.36 % | -99.73 % | -81.63 % | -4.43 % | -87.40 % | -15.74 % | 91.27 % | -95.05 % | 0.16 % | -90.14 % |